Paperpal Prime Logo

npj Schizophrenia : Impact Factor & More

eISSN: 2334-265XpISSN: 2334-265X
JournalOpen Access

Key Metrics

CiteScore
5
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q1Psychiatry and Mental Health
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on npj Schizophrenia

npj Schizophrenia Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Springer Nature
Language English
Frequency Continuous publication
Article Processing ChargesUSD 3590
Publication Time15
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Society/Institute/SponsorSchizophrenia International Research Society
FrequencyContinuous publication
Publication Start Year2015
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in npj Schizophrenia ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in npj Schizophrenia

Using smartphone-based assessment of social experience to predict relapse in first-episode psychosis.
  • 17 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Discriminative validity of Clinical High-Risk Status for Psychosis among help-seekers: a systematic review and meta-analysis.
  • 16 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Disrupted cerebellar interactions in the cerebellar-thalamo-cortical triple network model across risk states and first-episode psychosis.
  • 16 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Real-world treatment patterns, healthcare resource utilization and economic burden in U.S. adults with schizophrenia with and without tardive dyskinesia.
  • 14 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Glutathione-related redox imbalance and cognitive impairment in drug-naïve, first-episode schizophrenia: a focus on GSSG.
  • 9 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
East Asian herbal medicine as an adjunctive treatment for schizophrenia: a systematic review and meta-analysis.
  • 9 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Using smartphone-based assessment of social experience to predict relapse in first-episode psychosis.
  • 17 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Discriminative validity of Clinical High-Risk Status for Psychosis among help-seekers: a systematic review and meta-analysis.
  • 16 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Disrupted cerebellar interactions in the cerebellar-thalamo-cortical triple network model across risk states and first-episode psychosis.
  • 16 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Real-world treatment patterns, healthcare resource utilization and economic burden in U.S. adults with schizophrenia with and without tardive dyskinesia.
  • 14 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
Glutathione-related redox imbalance and cognitive impairment in drug-naïve, first-episode schizophrenia: a focus on GSSG.
  • 9 Jul 2026
  • Schizophrenia (Heidelberg, Germany)
East Asian herbal medicine as an adjunctive treatment for schizophrenia: a systematic review and meta-analysis.
  • 9 Jul 2026
  • Schizophrenia (Heidelberg, Germany)

FAQs on npj Schizophrenia